OBJECTIVE: The objective of this study was to systematically review the literature on animal ototoxicity from ototopical medications. A secondary objective was to assess the relevance of animal data to the use of ototopical drops in clinical situations involving humans.
STUDY DESIGN: We performed a MEDLINE search of the published literature using appropriate search terms to identify pertinent articles, which were reviewed, summarized, and tabulated.
RESULTS: One hundred seventy-three articles were reviewed; 61 articles were appropriate to the study question and were further analyzed.
CONCLUSIONS: Virtually all studies demonstrate that aminoglycoside antibiotics, when applied topically into the middle ear space, are ototoxic in experimental animals.
Get full access to this article
View all access options for this article.
References
1.
Proud GO,Mittelman H,Seiden GD.Ototoxicity of topically applied chloramphenicol.Arch Otolaryngol. 1968;87:580-7
2.
Stupp H,Kupper K,Lagler F, et al.Inner ear concentrations and ototoxicity of different antibiotics in local and systemic application.Audiology. 1973;12:350-63
3.
Koide Y,Hata A,Hando R..Vulnerability of the organ of Corti in poisoning.Acta Otolaryngol. 1966;61:332-44
4.
Brummett RE,Harris RF,Lindgren JA.Detection of ototoxicity from drugs applied topically to the middle ear space.Laryngoscope. 1976;86:1177-87
5.
Morizono T,Paparella MM,Juhn SK.Ototoxicity of propylene glycol in experimental animals.Am J Otolaryngol. 1980;1:393-9
6.
Barlow DW,Duckert LG,Kreig CS, et al.Ototoxicity of topical otomicrobial agents.Acta Otolaryngol (Stockh). 1994;115:231-5
7.
Gulick WL.The effects of chloramphenicol upon the electrical activity of the ear: long term data.Ann Otol Rhinol Laryngol. 1964;73:204-9
8.
Harada T,Nagai Y,Iwamori M, et al.Ototoxicity of neomycin and its penetration through the round window membrane into the perilymph.Ann Otol Rhinol Laryngol. 1986;95:404-8
9.
Hoffer ME,Balough BJ,Kopke RD, et al.Morphologic changes in the inner ear of Chinchilla laniger after middle ear administration of gentamicin in a sustained-release vehicle.Otolaryngol Head Neck Surg. 1999;120:643-8
10.
Hoffer ME,Allen KA,Kopke RD, et al.Transtympanic versus sustained-release administration of gentamicin: kinetics, morphology and function.Laryngoscope. 2001;111:1343-57
11.
Ikeda K,Morizono T..The preparation of acetic acid for use in otic drops and its effect on endocochlear potential and pH in inner ear fluid.Am J Otolaryngol. 1989;10:382-5
12.
Ikeda K,Morizono T..Effect of ototopic application of a corticosteroid preparation on cochlear function.Am J Otolaryngol. 1991;12:150-3
13.
Jinn TH,Kim PD,Russell PT, et al.Determination of ototoxicity of common otic drops using isolated cochlear outer hair cells.Laryngoscope. 2001;111:2105-8
14.
Kohonen A,Tarkkanen J..Cochlear damage from ototoxic antibiotics by intratympanic application.Acta Otolaryngol. 1969;68:90-7
15.
Mittelman H..Ototoxicity of “ototopical” antibiotics: past, present, and future.Trans Am Acad Ophthalmol Otolaryngol. 1972;76:1432-43
16.
Morizono T,Johnstone BM.Ototoxicity of chloramphenicol ear drops with propylene glycol as solvent.Med J Austral. 1975;2:634-8
Parker FL,James GWL.The effect of various topical antibiotic and antibacterial agents on the middle and inner ear of the guinea-pig.J Pharm Pharmac. 1978;30:236-9
19.
Patterson WC,Gulick WL.The effects of chloramphenicol upon the electrical activity of the ear.Ann Otol Rhinol Laryngol. 1963;72:50-5
20.
Rudnick MD,Guinsberg IA,Huber PS, et al.Aminoglycoside ototoxicity following middle ear injection.Ann Otol Rhinol Laryngol. 1980;89 (suppl 77): 1-28
21.
Russell PT,Church CA,Jinn TH, et al.Effects of common topical otic preparations on the morphology of isolated cochlear outer hair cells.Acta Otolaryngol (Stockh). 2001;121:135-9
22.
Strain GM,Merchant SR,Neer TM, et al.Ototoxicity assessment of a gentamicin sulfate otic preparation in dogs.Am J Vet Res. 1995;56:532-8
23.
Webster JC,McGee TM,Carroll R, et al.Ototoxicity of gentamicin. Histopathologic and functional results in the cat.Trans Am Acad Ophthalmol Otolaryngol. 1970;74:1155-65
24.
Wright CG,Meyerhoff WL,Halama AR.Ototoxicity of neomycin and polymyxin B following middle ear application in the chinchilla and baboon.Am J Otol. 1987;8:495-9
25.
Zappia JJ,Altschuler RA.Evaluation of the effect of ototopical neomycin on spiral ganglion cell density in the guinea pig.Hear Res. 1989;40:29-38
26.
MoraisD.Long term ototoxic effects of neomycin applied topically in the middle ear: a morphologic study in the guinea pig. J Laryngol OtolApril 1988.
27.
Chen JM,Kakigi A,Hirakawa H, et al.Middle ear instillation of gentamicin and streptomycin in chinchillas: morphologic appraisal of selective ototoxicity.J Otolaryngol. 1999;28:121-8
28.
Ikiz AO,Serbetcioglu B,Guneri EA, et al.Investigation of topical ciprofloxacin ototoxicity in guinea pigs.Acta Otolaryngol. 1998;118:808-12
29.
Sichel J-Y,Eliashar R,Plotnik M, et al.Assessment of vestibular ototoxicity of ear drops by recording of vestibular evoked potentials to acceleration impulses.Am J Otol. 2000;21:192-5
30.
Nuttal AL,Marques DM,Lawrence M.Effects of perilymphatic perfusion with neomycin on cochlear microphonic potential in guinea pig.Acta Oto-Larynsologica. 1977;83:393-400
31.
Brown OE,Wright CG,Meyerhoff WL.Topical agents: efficacy or treatment in humans.Workshop on chronic suppurative otitis media: etiology and management Ann Otol Rhinol Laryngol. 1988;131:38-40
32.
Brown OE,Wright CG,Edwards LB, et al.The ototoxicity of ceftazidime in the chinchilla middle-ear.Arch Otolaryngol. 1989;115:940-2
33.
Jakob T,Wright CG,Robinson K, et al.Ototoxicity of topical ticarcillin and clavulanic acid in the chinchilla.Arch Otolaryngol Head Neck Surg. 1995;121:39-43
34.
Sackett DL,Straus SE,Richardson WS, et alEvidence-based medicine: how to practice and reach EBM. 2nd editionEdinburgh: Churchill Livingstone; 2000:
35.
Bagger-Sjöbäck D,Lundman L,Nilsson-Ehle I..Ciprofloxacin and the inner ear—a morphological and round window membrane permeability study.ORL. 1992;54:5-9
36.
Gates GA.Safety of ofloxacin otic and other ototopical treatments in animal models and in humans.Pediatr Infect Dis J. 2001;20:104-7
37.
Claes J,Govaerts PJ,Van de Heyning PH, et al.Lack of ciprofloxacin ototoxicity after repeated ototopical application.Antimicrobial agents and chemotherapy. 1991;35:1014-6
38.
Kato M,Akahana K,Shimoda K.Lack of chondrotoxicity of ofloxacin otic solution on the auditory ossicle cartilages of juvenile guinea pigs.J Antimicrob Chemother. 1997;39:269-71
39.
Morizono T.Ototopical agents: ototoxicity in animal studies.Workshop on chronic suppurative otitis media: etiology and management Ann Otol Rhinol Laryngol. 1988;131:28-30
Goycoolea MV,Muchow D,Schachern P.Experimental studies on round window structure: function and permeability.Microsc Res Tech. 1997;36:201-11
42.
Becvarovski Z,Bojrab DI,Michaelides EM, et al.Round window gentamicin absorption: an in vivo human model.Laryngoscope. 2002;112:1610-3
43.
SchachernPABacterial tympanogenic labyrinthitis, meningitis and sensorineural hearing loss. Arch Otolaryngol Head Neck Surg1992.
44.
GoycooleaMV. The round window membrane under normal and pathological conditions. Acta Otolaryngol1992; 43–55.
45.
Nomura YAdvances in oto-rhino-laryngology. Pfaltz CR, ed. New York: S Karger; 1984:
46.
Bellucci RJ,Risher EG,Rhodin J.Ultrastructure of the round window membrane.Laryngoscope. 1972;82:1021-6
47.
SchachernPA. The normal chinchilla round window membrane. Arch Otolaryngol1982.
48.
Kawabata I,Paparella MM.Fine structure of the round window membrane.Ann Otol Rhinol Laryngol. 1971;80:13-26
49.
Goycoolea MV.Oval and round window membrane changes in otitis media in the human. An ultrastructural study.Acta Otolaryngol. 1995;115:282-5
50.
Goycoolea MV.Clinical aspects of round window membrane permeability under normal and pathological conditions.Acta Otolaryngol. 2001;121:437-47
51.
Lundman LA,Holmquist L,Bagger-Sjoback D.Round window membrane permeability. An in vitro model.Acta Otolaryngol. 1987;104:472-80
52.
Goycoolea MV,Muchow D,Schachern P.Experimental studies on round window structure: function and permeability.Laryngoscope. 1988;98:1-20
53.
Schuknecht HF,Gulya AJAnatomy of the temporal bone with surgical implications. Philadelphia: Lea & Febiger; 1986:
54.
Meyerhoff WL,Morizono T,Wright CG, et al.Tympanostomy tubes and otic drops.Laryngoscope. 1983;938:1022-7
55.
Sahni RS,Paparella MM,Schachern PA, et al.Thickness of the human round window membrane in different forms of otitis media.Arch Otolaryngol Head Neck Surg. 1987;113:630-4
56.
KellerhalsG. Horschaden durch ototoxische Ohrtropfen. HNO1978; 49–52.
57.
Hermansson A,Preliner K,Helolstrom S.Persistent structural changes in the middle ear mucosa of the rat, after an experimentally induced episode of pneumococcal otitis media.Acta Otolaryngol. 1990;109:421-30
58.
Goycoolea MV,Paparella MM,Goldberg B, et al.Permeability of the round window membrane in otitis media.Arch Otolaryngol Head Neck Surg. 1980;106:430-3
59.
Vernon J,Brummett R,Walsh T..The ototoxic potential in propylene glycol in guinea pigs.Arch Otolaryngol. 1978;104:726-9
60.
Schacht J.Ototoxicity: Basic science and clinical applications. New York Academy of Sciences; 1999:125-30.
